Abstract
Background:
Behavioral variant frontotemporal dementia (bvFTD) typically involves subtle changes in personality that can delay a timely diagnosis.
Objective:
Here, we report the case of a patient diagnosed of GRN-positive bvFTD at the age of 52 presenting with a 7-year history of narcissistic personality disorder, accordingly to DSM-5 criteria.
Methods:
The patient was referred to neurological and neuropsychological examination. She underwent 3 Tesla magnetic resonance imaging (MRI) and genetic studies.
Results:
The neuropsychological examination revealed profound deficits in all cognitive domains and 3T brain MRI showed marked fronto-temporal atrophy. A mutation in the GRN gene further confirmed the diagnosis.
Conclusions:
The present case documents an unusual onset of bvFTD and highlights the problematic nature of the differential diagnosis between prodromal psychiatric features of the disease and primary psychiatric disorders. Early recognition and diagnosis of bvFTD can lead to appropriate management and support for patients and their families. This case highlights the importance of considering neurodegenerative diseases, such as bvFTD, in the differential diagnosis of psychiatric disorders, especially when exacerbations of behavioral traits manifest in adults.
Keywords
INTRODUCTION
Behavioral and psychiatric features can be observed in a wide range of neurodegenerative diseases at both late and early stages [1, 2]. In the latter scenario these can be erroneously attributed to a primary psychiatric disease, resulting in a delay in the diagnosis [1]. In fact, 50% of these patients are initially diagnosed with a primary psychiatric disorder [3].
Early-stage behavioral variant frontotemporal dementia (bvFTD) proves especially challenging to discriminate from psychiatric diseases such as bipolar disorder, major depressive disorder, obsessive-compulsive disorder, schizophrenia, catatonia, and personality disorders [4]. Early decline in social conduct with behavioral changes such as apathy, disinhibition, and irritability as well as stereotyped movements, repetitive gestures and a shift in eating habits have been described as typical early-onset features of both genetic and sporadic bvFTD [5–7]. Additional attributes include emotional blunting, general loss of insight, distractibility, loss of volition and relative sparing of memory. The onset is often subtle and involves mild changes in personality and values. These can be misunderstood by relatives so that patients get referred to a specialist only later. Furthermore, these very early stages of bvFTD can be misdiagnosed even by expert physicians [4].
Very few cases of patients diagnosed with a personality disorder preceding bvFTD have been reported. Borderline personality disorder and narcissistic personality disorder (NPD) have been described to anticipate the diagnosis of bvFTD by 5 years [8] and decades [9], respectively. However, none of these patients had a diagnosis of bvFTD confirmed by pathology or genetic screening.
We report the first case of a GRN-mutation positive patient who was diagnosed with NPD seven years before being referred to neurological examination. We hope that this case report will be helpful in widening the known spectrum of the prodromal features of bvFTD and its genotype-phenotype correlations.
Case presentation
The patient is a 52-year-old woman with a graduate-level education, who previously worked as a physiotherapist. She had an unremarkable past medical history and did not take any medication. She was not used to drinking or smoking. She had a positive family history of neurologic disease. Her mother’s cousin had a diagnosis of Alzheimer’s dementia at the age of 54 years. Moreover, her father was diagnosed with bipolar disorder at the age of 20 years. Her paternal grandfather suffered from a non-specified personality disorder. Her brother was reported to show some compulsive behavior.
The caregivers noticed a series of unusual behaviors in the patient since when she was 45 years old. When specifically asked about the onset of these, the caregivers reported that they had been occasionally present since young adulthood but became increasingly evident and hard to ignore from that moment. The first minor behavioral traits showed by the patient when she was young included a sense of envy towards the people close to her as well as arrogance in dealing with basic social interactions. She was reported to have acted exploitatively towards others for futile reasons. Furthermore, she often behaved like she needed others’ approval or admiration. Finally, she was exaggeratedly preoccupied with fantasies of impossible romances or by the desire to be adulated by others due to her beauty. She was labeled as a strange and unique character in the family. Despite these features, the patient kept her appearance relatively low-profile, worked as a physiotherapist, maintained long-lasting friendships, and also volunteered her services for her community, until 45 years. From that moment, the obsession with her appearance worsened: she dyed her hair platinum blonde, and she drastically increased the rate of pictures posted on social media. She impersonated diva-like figures, lived romantic movies-like fantasies, and dramatized everyday events. She produced some calendars where she had been photographed in model-like postures. She started involving herself in extramarital relationships, leading to the end of her marriage and her husband gaining custody of their two children. This had no apparent emotional fallout on the patient. Only at that point, did she receive a diagnosis of NPD. This behavioral profile remained stable for a further 5 years.
At the age of 50 years, the patient started manifesting unusually aggressive behaviors towards colleagues at work and emotional detachment from the people she was close with. She started to collect worthless objects such as watches, smartphones, and pens, and she started investing money impulsively. She underwent an antipsychotic treatment with dopamine-antagonists which was partially successful in limiting aggressive and disinhibited behaviors. One year later, stereotypies of both motor (swinging-like movements of the head and the trunk) and vocal nature as well as language deficits (reduction in verbal fluency) started to be displayed. Furthermore, she developed hyperorality with preference for carb-rich food. Over the course of 6 years since the onset of the first psychiatric features, the patient gradually lost her instrumental and functional independence. At the time of our observation, she revealed an already late-stage cognitive impairment, with ideomotor slowing and confusion, dramatically reduced spontaneous speech fluency and discernible only abundant vocal stereotypies. Her understanding of easy tasks was heavily compromised. She also showed reduced arm swinging on the right and bradikynesia bilaterally, worse on the left side. Frontal release signs were positive. The patient did not have any insight of the symptoms. The caregivers reported that the patient gained 10 kg from the onset of the first symptoms to the time of the observation.
MATERIAL AND METHODS
Neuropsychological examination
The neuropsychological evaluation targeted all domains of cognition (memory, attention, executive function, language, visuospatial, and social cognition), including tests aimed at the behavioral features. Participants’ relatives/caregivers were present when the questionnaires were administered and allowed to help them with the responses, whenever necessary.
MRI and CSF studies
Structural 3T magnetic resonance imaging (MRI) was performed. T1 and T2 and FLAIR weighted sequences were performed. The patient underwent lumbar puncture for the dosage of cerebrospinal fluid (CSF) biomarkers of neurodegeneration (amyloid-beta 1-42 [Aβ42], total tau and phospho-tau181) according to standard procedures. The CSF Aβ42, total tau, and p-tau181 levels were measured by chemiluminescent immunoassay CLEIA (Lumipulse G β-amyloid 1–42, Lumipulse G Total Tau, Lumipulse G pTau181, Fujirebio Europe N.V., Gent, Belgium) on fully automatic platform (Lumipulse G600II, Fujirebio Europe N.V., Gent, Belgium). All the assays were performed according to manufacturer’s protocols. For the interpretation of the cerebrospinal biomarker results, the following cut-off values were considered: Aβ42 > 599 pg/mL, tau < 342 pg/mL, p-tau181 < 57 pg/mL.
Genetic analysis
The proband provided written informed consent for molecular testing for frontotemporal dementia. Genomic DNA was isolated from peripheral blood sample using QIAsymphony (Quiagen, Solna, Sweden). Genomic library was prepared with Illumina-DNA Prep with Enrichment and sequencing analysis was performed with TruSight One Expanded exome on a NexSeq550 System, following manufacturer’s instructions (Illumina, San Diego, CA, USA).
RESULTS
Neuropsychological and nutritional examination
The neuropsychological examination confirmed a dramatically reduced speech rate, due to behavioral/praxis deficit since the patient was able to correctly pronounce a few words on different occasions with no phonological and semantic similarities, hence probably not related to a primary language problem. However, the performance in both semantic and phonemic fluency was significantly impaired. Writing was also found to be impaired, but object-naming was relatively preserved; perseveration was common to both motor and verbal answers. For this reason, the neuropsychological examination was integrated with qualitative data and features. Executive functioning was revealed to be dramatically impaired with a score of 2 in the Frontal Assessment Battery (FAB) [10]. More specific aspects of executive functions such as working memory and planning were also severely impaired as showed by the performance in the digit span backwards and by the performance in the copy of the complex Rey-Osterrieth figure. Indeed, no visuo-constructive difficulties were observed in the copy of simpler geometrical figures, indicating a more prominent impairment in the planning aspects of the drawing. Qualitatively, we did not observe the significant presence of episodic memory deficits, with greater accuracy in the facilitated recall. No attentional difficulties were observed with the patients being vigilant and collaborative throughout the evaluation. The Neuropsychiatric Inventory highlighted the presence of marked changes in terms of physical and verbal aggressivity, irritability, disinhibition, apathy and hyperorality. Also, the functional level in daily living was investigated showing a loss of most of Instrumental Activities of Daily Living (8/8) and Activities of Daily Living (5/6). The nutritional evaluation revealed a severe alteration of eating behavior: the patient met the criteria for 1st-grade obesity and sarcopenia.
MRI and CSF studies
Brain MRI (Fig. 1) showed diffuse enlargement of the convexity sulci and of the ventricular complexes, frontal and parietal bilateral atrophy (Global Cortical Atrophy score: 2 [11]; Koedam score: 2 [12] and bilateral hippocampal atrophy (Middle Temporal Atrophy score: 2) [13]. CSF biomarkers were negative for Alzheimer’s disease (Aβ42: 830 g/mL; total tau: 416 /mL; p-tau181 : 23.10 pg/mL) and indicated a Suspected Non Alzheimer Pathology (SNAP) [14].

Representative MRI T2 FLAIR weighted images in axial (A, B, C) and coronal slices (D) show fronto-temporal cortical atrophy. Hippocampal structures appear moderately atrophic at coronal FLAIR (D).
Genetic analysis
Finally, genetic analysis (pedigree of the patient in Fig. 2) confirmed the clinical suspect of bvFTD [5]. Next generation sequencing analysis revealed the pathogenic variant c.709-2A>T at heterozygous state in the GRN gene (NM_002087.4). It is predicted to disrupt the highly conserved acceptor splice site of intron 7. This variant has previously been described as disease disease-causing mutation for FTD [15, 16].The proband’s mother and brother refused to perform genetic testing for evaluation of the GRN mutation.

The pedigree of the family.
DISCUSSION
This is the first reported case of genetically defined bvFTD-caused NPD. The clinical spectrum of prodromal bvFTD encompasses several clinical features often leading to misdiagnosis of primary psychiatric diseases [1, 4]. This occurred to our patient, who had received a diagnosis of NPD 5 years before being referred to our outpatient service.
According to DSM-5, NPD can be diagnosed when a patient has an inflated sense of their own importance, often fantasizing about unlimited success, power, brilliance, or perfect love or exaggerating their achievements. They may believe that they are unique or exceptional and only deserve to be associated with other people (or institutions) who share a high status or are equally “special.” They crave excessive admiration and may feel entitled to certain privileges; they re-orient their behavior to obtain others’ praise. They may also exploit others for their own benefit, lack empathy, and display arrogant or haughty behaviors. They are often envious of others, or they believe that others are envious of them [17–19].
Both personality disorders and early-stage bvFTD involve subtle change in personality. In particular, narcissistic personalities and bvFTD may share traits like puerilism, selfishness, disregard for others [4]. However, some of these features are distinctive of one rather than the other condition, such as the presence of an exaggerated sense of self-grandiosity, which is absent in bvFTD. Other types of behavioral alterations can be revealed to be different in the two conditions if investigated from a neuropsychological viewpoint. For example, despite sharing the lack of empathy, individuals with bvFTD exhibit impairments in cognitive empathy [20], whereas those with NPD demonstrate deficiencies in emotional empathy [21].
Finally, some actions can be present in both NPD and bvFTD but are explained by different drives. For instance, patients with bvFTD may demonstrate acquired antisocial behaviors, such as patients with NPD. Nevertheless, in bvFTD these behaviors are often impulsive and result from disinhibition rather than intentional aggression [22]. In bvFTD, disinhibition rather than a deep-seated need for admiration and validation is also at the basis of conducts that can be confounded with attention-seeking behavior, which is seen in NPD. These include inappropriate jokes, overfamiliarity, loud or disruptive actions, and unusual dressing.
Personality disorders have been reported only in very few cases as possible prodromal manifestations of bvFTD [8, 9]. In fact, an NPD diagnosis preceding the development of bvFTD features in a 73-year-old man has been reported only once [9]. The diagnosis of NPD was made retrospectively according to features that had been present in the patient since young adulthood. This led the authors to speculate whether this kind of long-lasting psychiatric feature could be reframed as prodromal features of a disease that would become overt only decades later. This was also the case with our patient: she showed minor behavioral disturbances since young adulthood that, in hindsight, already fell under the spectrum of the later-diagnosed NPD.
In the past, the concept of selective vulnerability was introduced to clarify why some networks are more susceptible to neurodegeneration, and why the same pathological process manifests in diverse clinical presentations among individuals [23]. Non-pathological personality traits such as high neuroticism [24, 25] and low conscientiousness were associated with dementia and mild cognitive impairment [25]. Environmental factors have been speculated to contribute to increased susceptibility to develop primary progressive aphasia [26], which belongs to the same neuropathological spectrum as bvFTD. It has been speculated that NPD and other affective psychiatric disorders could increase the neurobiological vulnerability for bvFTD [9].
A common biological framework for the shared clinical features between bvFTD and NPD has been suggested by neuroimaging studies, where both regional atrophy and connectivity alterations located in the fronto-temporal and insular cortices are relatively robust findings among the spectrum of both bvFTD and narcissistic behavioral traits [27–35].
Exploring the potential links between personality disorders and neurodegenerative conditions, it is worth noting that certain personality disorders like schizotypal, avoidant, obsessive-compulsive, histrionic, and narcissistic personality disorders have been linked to a higher risk of developing Alzheimer’s disease [36]. However, epidemiological evidence on the link between NPD and bvFTD has not been reported yet. More generally, no consensus on environmental psychosocial risk factors for the development of bvFTD has been reached [37–39]. A bipolar disorder-linked increase in the risk of developing a subsequent bvFTD [40] has been suggested. However, some cases of long-lasting bipolar disorder suggest that these findings could be biased by early presentations of bvFTD [40].
The possibility that premorbid personality disorders could have an influence in the clinical phenomenology of subsequent cognitive decline, i.e., the presence of a pathoplastic effect of personality, has also been previously studied in retrospective studies [41]. Despite the confusion between long-standing premorbid personality traits and transitory personality changes has hampered most of these studies [41], there is evidence of a moderate link between traits such as neuroticism and low tolerance towards frustration and later personality changes [42] and depression [43], respectively.
Life-long subtle neuropsychiatric traits such as reduction in empathy and flexibility were retrospectively demonstrated in C9orf72 carriers [44]. Impaired executive functions, attention and social cognition have been found to be present in pre-symptomatic GRN mutation carriers up to eight years before the onset of the full-blown disease [45–47]. An abnormally high load of white matter hyperintensities have been seen in these asymptomatic carriers [48] This suggests that neurodegeneration in bvFTD starts long before the features of the disease become overt. However, GRN-mutation carriers who develop bvFTD have not been associated yet with specific clinical symptoms or pre-morbid personality traits [45, 46].
Despite having received a diagnosis of NPD, our patient did not meet the DSM-5 criteria “D” for such diagnosis. This addresses an abnormal functioning of the patient in respect to the norms of their socio-cultural environment or developmental stage. The fact that the patient managed to conduct a relatively normal life in terms of social functioning before the later exacerbation of her behavioral traits should have been raised as a red flag for an alternative diagnosis. In fact, according to DSM-5, typical personality disorders must be present since an earlier age. Deviations from these patterns of presentation should make the clinician aware that possible neurodegenerative diseases such as bvFTD should be included in the differential diagnosis.
Asymmetrical frontal brain atrophy with parietal involvement has been reported in GRN-mutation positive FTD [49, 50]. In fact, these features were present in our patient. The clinical correlate of these neuroimaging peculiarities has not been explained yet. Further cases of GRN-mutation positive bvFTD patients could clarify if this is related to particular psychiatric presentations. Another perplexing finding is the absence of a clear bvFTD diagnosis in the patient’s father. Nevertheless, considering that he passed away at the age of 72, it is plausible that this case represents an under-diagnosis. Of note, GRN-positive bvFTD is known for its high penetrance but relatively late onset, with an average age of onset at around 60 years old [51].
In conclusion, our case report confirms that unusual clinical features, secondary to underlying neurodegeneration, can manifest many years earlier than typical onset of bvFTD, resembling primary psychiatric disorders. Describing additional cases would help unravel whether the behavioral profile of these patients can be affected by the disease earlier than previously thought. Understanding these early manifestations is crucial for accurate diagnosis and management, as these patients could potentially benefit from early administration of targeted and new disease-modifying treatments.
AUTHOR CONTRIBUTIONS
Daniele Urso (Conceptualization; Investigation; Methodology; Project administration; Supervision; Writing – original draft; Writing – review & editing); Marco Michelutti (Conceptualization; Investigation; Methodology; Writing – original draft; Writing – review & editing); Valentina Gnoni (Writing – review & editing); Alessia Giugno (Writing – review & editing); Chiara Zecca (Data curation; Writing – review & editing); Davide Vilella (Writing – review & editing); Maria Accadia (Data curation; Writing – review & editing); Roberta Barone (Data curation; Writing – review & editing); Maria Teresa Dell’Abate (Data curation; Writing – review & editing); Roberto De Blasi (Writing – review & editing); Paolo Manganotti (Writing – review & editing); Giancarlo Logroscino (Conceptualization; Methodology; Project administration; Supervision; Writing – original draft; Writing – review & editing).
Footnotes
ACKNOWLEDGMENTS
The authors have no acknowledgements to report.
FUNDING
This work has been supported with the funding of Regione Puglia and CNR for Tecnopolo per la Medicina di Precisione. D.G.R. n. 2117 of 21.11.2018 (CUPB84I18000540002)—C.I.R.E.M.I.C. (Research Center of Excellence for Neurodegenerative Diseases and Brain Aging)—University of Bari “Aldo Moro”.
CONFLICT OF INTEREST
The authors have no conflict of interest to report.
DATA AVAILABILITY
Data sharing is not applicable to this article as no datasets were generated or analyzed during this study.
